tiprankstipranks
Advertisement
Advertisement

GRFS Stock Latest News

New conditions imposed on Grifols by Health Canada, CBC News reports
The FlyNew conditions imposed on Grifols by Health Canada, CBC News reports
5d ago
GRFS
Grifols rallies after board approves IPO of U.S. Biopharma business
PremiumThe Fly
Grifols rallies after board approves IPO of U.S. Biopharma business
13d ago
GRFS
Grifols Weighs U.S. IPO of Biopharma Subsidiary to Support Self-Sufficiency Strategy
PremiumCompany Announcements
Grifols Weighs U.S. IPO of Biopharma Subsidiary to Support Self-Sufficiency Strategy
13d ago
6K
GRFS
Grifols to evaluate potential IPO of U.S. Biopharma business
PremiumThe Fly
Grifols to evaluate potential IPO of U.S. Biopharma business
13d ago
GRFS
Grifols price target lowered to EUR 11 from EUR 12 at Deutsche Bank
PremiumThe Fly
Grifols price target lowered to EUR 11 from EUR 12 at Deutsche Bank
19d ago
GRFS
Grifols shares results of Chronos Platforms identifying early Parkinson’s
PremiumThe FlyGrifols shares results of Chronos Platforms identifying early Parkinson’s
21d ago
GRFS
Grifols downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Grifols downgraded to Equal Weight from Overweight at Morgan Stanley
28d ago
GRFS
Grifols Doubles 2025 Profit and Secures Key Plasma and Fibrinogen Approvals
Premium
Company Announcements
Grifols Doubles 2025 Profit and Secures Key Plasma and Fibrinogen Approvals
1M ago
6K
GRFS
Grifols Swings to Profit as Board Signs Off 2025 Annual Accounts
PremiumCompany Announcements
Grifols Swings to Profit as Board Signs Off 2025 Annual Accounts
1M ago
6K
GRFS
Grifols reports Q4 adjusted EBITDA EUR 467M, consensus EUR 469.7M
PremiumThe Fly
Grifols reports Q4 adjusted EBITDA EUR 467M, consensus EUR 469.7M
1M ago
GRFS
Grifols sees 2026 adjusted EBITDA growth 5%-9%
PremiumThe Fly
Grifols sees 2026 adjusted EBITDA growth 5%-9%
1M ago
GRFS
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
GRFS
Grifols Adjusts Board Secretariat Roles Effective January 1, 2026
PremiumCompany AnnouncementsGrifols Adjusts Board Secretariat Roles Effective January 1, 2026
3M ago
6K
GRFS
Grifols price target lowered to EUR 13.50 from EUR 15 at Barclays
Premium
The Fly
Grifols price target lowered to EUR 13.50 from EUR 15 at Barclays
3M ago
GRFS
Grifols Achieves EMA Certification for Egyptian Plasma Operations
Premium
Company Announcements
Grifols Achieves EMA Certification for Egyptian Plasma Operations
4M ago
6K
GRFS
Grifols price target lowered to EUR 8.50 from EUR 9 at JPMorgan
PremiumThe Fly
Grifols price target lowered to EUR 8.50 from EUR 9 at JPMorgan
4M ago
GRFS
Grifols price target lowered to $10 from $10.30 at JPMorgan
PremiumThe Fly
Grifols price target lowered to $10 from $10.30 at JPMorgan
4M ago
GRFS
Grifols SA Reports Strong Q3 Earnings Amid Challenges
PremiumCompany Announcements
Grifols SA Reports Strong Q3 Earnings Amid Challenges
5M ago
GRFS
Grifols SA Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Grifols SA Reports Strong Q3 2025 Financial Results
5M ago
GRFS
Grifols Reports Strong Q3 2025 Financial Performance with Biopharma Growth
PremiumCompany AnnouncementsGrifols Reports Strong Q3 2025 Financial Performance with Biopharma Growth
5M ago
6K
GRFS
Grifols reports Q3 adjusted EBITDA of EUR 482M, up 8.8% in constant currency
Premium
The Fly
Grifols reports Q3 adjusted EBITDA of EUR 482M, up 8.8% in constant currency
5M ago
GRFS
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
GRFS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >